about
Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingChronic active B-cell-receptor signalling in diffuse large B-cell lymphomaDeep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAsDifferential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphomaA cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor scoreA prediction-based resampling method for estimating the number of clusters in a dataset.Role of the tumor microenvironment in mature B-cell lymphoid malignanciesLymphoma Immunotherapy: Current StatusNF-κB in cellular senescence and cancer treatmentNovel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewStromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in miceA phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma.The tumor microenvironment shapes hallmarks of mature B-cell malignancies.Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.Integrative systems medicine approaches to identify molecular targets in lymphoid malignanciesEvolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent updateBone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistanceCD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesisDiffuse large B-cell lymphoma: current strategies and future directionsOncogenically active MYD88 mutations in human lymphomaThe sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activityDevelopment and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCLAnti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-CellsExploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphomaLeveraging models of cell regulation and GWAS data in integrative network-based association studiesA strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphomaCommon variants on 14q32 and 13q12 are associated with DLBCL susceptibilityNetwork medicine: a network-based approach to human diseaseMature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.A microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphomaPredicting cancer drug mechanisms of action using molecular network signatures.Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data.Novel prognostic genes of diffuse large B-cell lymphoma revealed by survival analysis of gene expression data.Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression dataSupervised group Lasso with applications to microarray data analysis.Additive risk survival model with microarray dataPrognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.Diffuse large B-cell non-Hodgkin lymphoma involving the unilateral carotid space in an elderly man: A case report.Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.
P2860
Q24597424-E2C8ED23-B7A6-4B0E-AA14-1E855DC6B89EQ24612248-AE4F0F4D-1D0D-4CF8-AE53-240619D00E41Q24613755-0CB8C9DE-324D-4236-BFE6-EA6D361379D6Q24618086-89A761FC-0391-40C7-8021-47C712D44134Q24643447-A05A5099-B88E-4BFA-AA0A-4123AF8E6DD6Q24653343-27833901-4E33-406B-9339-C980903C1709Q24802783-25B208EA-5958-434E-B3F6-50E157919BF1Q26748775-F7634DE3-0918-4B6C-BDA1-414D2583CA81Q26782902-A0FBAA2C-9BB2-4822-85CC-517799B31A45Q27007045-C7F3D763-1D4F-4E22-ACD0-86DCB1296F12Q27304386-D1425D11-9486-45F1-8D20-F3CDC8E3EF48Q27305136-4FD35187-C63E-4C85-86AF-C3F894DE4D3AQ27320446-AFC7F2A9-B636-424F-A215-35ACCC5F79F6Q27687567-257B193A-E690-426C-B78D-ED8F17503477Q27851546-FC705F7A-CC98-4052-BB4C-050D6CBCF74BQ28067817-EA97773C-257A-41E2-90C4-B71B5D42C5CDQ28078869-0C205343-4D58-47D7-8F1D-6646762A4A0AQ28243054-AB125DC8-529B-4D55-8B2D-A8271031F2AAQ28265732-DE1E20AE-E199-490B-8528-376FC8820833Q28269136-DAD1BB76-ED57-4568-B026-136DFD7A9871Q28301648-050BFF69-AC4C-4085-9F30-A9BD61CA0A87Q28487756-23207DC7-6B34-4114-BCD6-0F32425E539BQ28543490-0E0E95FE-1879-4596-9AA4-DD3CC70A3852Q28551184-60D0B070-782B-46D3-8CDC-E0185C81DFA2Q28649793-D168CAEF-C614-4E44-ADDA-8CF90783F239Q28704307-D5745599-94CE-47E4-BF71-5FEA7E8E3579Q28741787-3B19FFEA-B510-41BC-8184-BEB2A34C8150Q28943537-20A599A7-64C9-4424-9743-8147662DBDA3Q29547462-055B153D-8E7E-4541-BC59-340D9B32C797Q30240133-5CE669B7-516D-4FDD-B960-A4DA773888CDQ30485971-45709A0F-CC74-43EA-9273-D2371BE427EBQ30573575-E73DC5F8-A9C7-4DD3-A93A-6E86EC59F610Q30584472-0440F6D6-4AA5-4815-A83F-2518FDF301E6Q31028064-003D3FDA-9576-486A-88C9-C9E640368391Q31095260-161F2DFF-FC84-483B-9B38-DFDCDCF027AAQ31102317-216110D8-4803-4656-A53B-98C90621F365Q31115192-4DF592E4-8A8D-49FE-83D8-579DDC754CFEQ31116522-F5E76EEA-1E79-4969-928F-9630CFD4D916Q33168184-7D30B8F2-DE73-4E78-AE3E-3C8B8CEB0DADQ33396833-0215CF12-BD11-435F-8079-352C63B20073
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Stromal gene signatures in large-B-cell lymphomas
@ast
Stromal gene signatures in large-B-cell lymphomas
@en
Stromal gene signatures in large-B-cell lymphomas
@nl
type
label
Stromal gene signatures in large-B-cell lymphomas
@ast
Stromal gene signatures in large-B-cell lymphomas
@en
Stromal gene signatures in large-B-cell lymphomas
@nl
prefLabel
Stromal gene signatures in large-B-cell lymphomas
@ast
Stromal gene signatures in large-B-cell lymphomas
@en
Stromal gene signatures in large-B-cell lymphomas
@nl
P2093
P50
P3181
P356
P1476
Stromal gene signatures in large-B-cell lymphomas
@en
P2093
A Lopez-Guillermo
A Martinez
D D Weisenburger
D Dierickx
E Hartmann
P304
P3181
P356
10.1056/NEJMOA0802885
P407
P577
2008-11-27T00:00:00Z